Navigation Links
First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder

whom previous treatments had not worked," said Mr. Prokar Dasgupta, consultant urologist at Guy's Hospital, honorary senior lecturer at King's College London, and a co-principal investigator of the study. "These were patients who were seriously affected by their OAB symptoms. At basline, 81 percent of patients in the botulinum toxin type A treatment group and 67 percent in the placebo treatment group were experiencing urge urinary incontinence daily."

OAB is more common than osteoarthritis or diabetes(1,2) and is estimated to affect 16-17% of the population in the U.S. and Western Europe.(3) In addition, the economic burden of OAB is substantial. In the U.S., for example, the total economic cost of OAB has been estimated at $12 billion in 2000 (including costs incurred in the community and institutions).

About the Study

The double-blind trial included 34 patients with OAB and confirmed IDO who had failed on a trial of anticholinergic therapy for six weeks or more due to either poor efficacy or tolerability. They were randomly assigned to treatment with BTX-A 200 U (BOTOX(R)) (16 patients) or placebo (18 patients). The primary outcome measure was change in maximum cystometric capacity (MCC), a measure of urinary bladder capacity. Secondary outcome measures included changes in OAB symptoms, other measures related to urinary bladder filling and pressure, symptoms of urgency and incontinence, and quality of life (QoL). Patients were assessed at 4 and 12 weeks post-injection, at which point the study was unblinded; BTX-A patients were further followed until 24 weeks.

BTX-A treatment significantly increased MCC vs. baseline at 4 weeks (by about 72%) and 12 weeks (by about 45%), compared to a 15 percent decrease in placebo patients at both time points. The differences between MCC changes for the BTX-A and placebo groups were significant at both time points (p<0.0001 and p<0.0011, respectively). Likewise, at 4 and 12 weeks compared to baseline,
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:9/30/2014)... This report analyzes the worldwide markets for Enteral ... Enteral Feeding Pumps, Nasogastric Tubes, and Others. The ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The report ...
(Date:9/30/2014)... , Sept. 30, 2014  Hologic, Inc. (NASDAQ: ... MacMillan , Hologic,s President and Chief Executive Officer, will ... on October 1, the first day of Breast Cancer ... the Company,s campaign focused on the important benefits of ... by the FDA as clinically superior to traditional mammography. ...
(Date:9/30/2014)... ROCKVILLE, Md. , Sept. 30, 2014 /PRNewswire/ ... natural way to modernize medicine, announced today the ... line of nutraceuticals developed to address men and ... staying healthy and vibrant into old age while ... line includes three condition-specific, whole-food and herb-based formulas, ...
Breaking Medicine Technology:Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... Md., March 20, 2012   Sunpeaks Ventures, Inc. ... "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare ... that Clotamin® will soon be available at Navarro ... Founded in 1940, Navarro Discount Pharmacies, Inc. is ...
... FARMINGTON, Conn., March 20, 2012 /PRNewswire-iReach/ -- ... 3 significant Biotech and Healthcare conferences scheduled for Boston, MA ... Annual mHealth World Congress July 25-27, ... in the healthcare industry from the way consumers engage in ...
Cached Medicine Technology:Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies 2Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012 2Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012 3
(Date:9/30/2014)... UC Irvine immunologists reveals new information about how our ... that determines how the body,s ability to fight infection ... Immunology , neurology professor Dr. Michael Demetriou, postdoctoral scholar ... a critical mechanism underlying how T cells are created, ... cell is a type of blood cell called a ...
(Date:9/30/2014)... September 30, 2014 Glycodrive , ... Nutraceuticals designed to help maximize lean, strong muscle growth ... body’s absorption of glucose has caught the attention of ... main purpose behind Glycodrive is to help the body ... reports Michaels. “Carbs are essential in the muscle-building process, ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
(Date:9/30/2014)... 2014 For most families, fall means ... pumpkin patch or annual festival. For millions of children, ... like the respiratory infection Enterovirus D68. , While ... small percentage – especially children with weakened immune systems ... the Enterovirus is prompting hospitals across the country to ...
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set ... Nashville, Tennessee. RMS welcomes the launch of an entirely ... of a new treatment center for the Lung Institute. ... Institute to Nashville, the hope is to bring awareness ... diagnosed and undiagnosed. With Nashville being a hub for ...
Breaking Medicine News(10 mins):Health News:UCI study uncovers important process for immune system development 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:Regenerative Medicine Solutions Expanding 2
... LAUDERDALE, Fla., June 23 MEDmarketplace.com announced ... MedAssets Supply Chain Systems, effective June 1, 2009. ... buying and selling of unused and excess medical equipment. ... customers, including 1,800 hospital and IDN facilities and non ...
... But for those suffering from stress, money trouble or chronic ... find. Now, a Tel Aviv University researcher says we should ... Tel Aviv University,s Sackler School of Medicine is engaged in ... of happiness," which may be 50% responsible for an optimistic ...
... Senate Hearing, and Urge Legislators To Request Fund Research , ... throughout the U.S. with type 1 diabetes are in Washington, D.C. ... They,ll be joined by JDRF International Chairman Mary Tyler ... platinum group The Jonas Brothers, boxing legend Sugar Ray Leonard ...
... avoid dreaded "doughnut hole" , , WASHINGTON, June 23 ... million older Americans will have fallen into the "doughnut hole"--a ... on the hook for all of their own drug costs ... online resource to help older Americans avoid this dreaded coverage ...
... giving the Food and Drug Administration (FDA) the power to ... House ceremony today. , , (Logo: ... government can now regulate the amount of nicotine in tobacco ... detailed on the label and prohibit deceptive marketing and ads ...
... most frequent congenital abnormality of the small bowel and ... asymptomatic but approximately 4% are symptomatic with complications such ... al presents a case of Meckel,s diverticulum masked by ... foundings will be published on June 14, 2009 in ...
Cached Medicine News:Health News:MedAssets Awards MEDmarketplace.com Contract for Idle Capital Equipment, Hospital Equipment and Supplies 2Health News:In pursuit of a happiness gene 2Health News:150 Children, Celebrities With Type 1 Diabetes Converge on Capitol Hill for JDRF's Children's Congress 2009 2Health News:150 Children, Celebrities With Type 1 Diabetes Converge on Capitol Hill for JDRF's Children's Congress 2009 3Health News:150 Children, Celebrities With Type 1 Diabetes Converge on Capitol Hill for JDRF's Children's Congress 2009 4Health News:AARP Launches Money-Saving Prescription Drug Resource 2Health News:AARP Launches Money-Saving Prescription Drug Resource 3Health News:Lung Cancer Alliance Hails Signing of Tobacco Control Legislation Into Law; Urges Action on Lung Cancer 2
... is a suture option for ... diameter looped FiberWire products allow ... extensor tendon repairs while reducing ... passes. FiberLoop is available with ...
... study remains the mainstay in a urologic workup. ... patient needs for an accurate, easy-to-use in-office uroflow ... onset of urine flow and automatically ends when ... urine flow. There is no need to have ...
UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
... Ureteral Stents feature teardrop shaped kidney curls ... hydrophilic coating for ease of placement, and ... the trigone. The Multi-Flex advanced design has ... segment provides pushability for placement, and strength ...
Medicine Products: